These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15774171)

  • 1. [The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Liu LX; Zhu AL; Chen W; Guo HX; Wang XQ; Liu ZH; Zhang TD; Jiang HC; Wu M
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):33-6. PubMed ID: 15774171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of arsenic trioxide on human hepatocarcinoma in nude mice.
    Xu HY; Yang YL; Liu SM; Bi L; Chen SX
    World J Gastroenterol; 2004 Dec; 10(24):3677-9. PubMed ID: 15534931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.
    Wang SS; Zhang T; Wang XL; Hong L; Qi QH
    World J Gastroenterol; 2003 May; 9(5):930-5. PubMed ID: 12717832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
    Liu L; Qin S; Chen H; Wang J; Chen H; Ma J; Liu W
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):367-9. PubMed ID: 11135700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y; Gao F; Song W
    Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.
    Liu JW; Tang Y; Shen Y; Zhong XY
    World J Gastroenterol; 2003 Jan; 9(1):65-8. PubMed ID: 12508353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats.
    Tan B; Huang JF; Wei Q; Zhang H; Ni RZ
    World J Gastroenterol; 2005 Oct; 11(38):5938-43. PubMed ID: 16273603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
    Li X; Ding X; Adrian TE
    Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
    Zhang T; Wang SS; Hong L; Wang XL; Qi QH
    J Exp Clin Cancer Res; 2003 Mar; 22(1):61-8. PubMed ID: 12725324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer.
    Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB
    J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor effect of arsenic trioxide on mice experimental liver cancer].
    Chen H; Qin S; Pan Q
    Zhonghua Gan Zang Bing Za Zhi; 2000 Feb; 8(1):27-9. PubMed ID: 10712780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
    Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
    Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.
    Lin LM; Li BX; Xiao JB; Lin DH; Yang BF
    World J Gastroenterol; 2005 Sep; 11(36):5633-7. PubMed ID: 16237756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells.
    Sadaf N; Kumar N; Ali M; Ali V; Bimal S; Haque R
    Life Sci; 2018 Jul; 205():9-17. PubMed ID: 29738779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
    Liu L; Chen BA; Qin SK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):67-72. PubMed ID: 21434348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis.
    Han YH; Kim SZ; Kim SH; Park WH
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F511-20. PubMed ID: 17507598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.